New Intelligence Report on “Genome Editing Market to 2025” is recently published by The Insight Partners. The report aims to provide leading industry players with information such as company profiles, products and services offered, financial information of last 3 yesars, key development in past five years
The genome editing market in different regions is analyzed by the PEST analysis and the SWOT analysis is provided for the profiled companies in our scope of study. For instance, the PEST analysis of the North America region contain political factor – changes in the regulation for the crops, the economic factor – funding for the genome editing, social factor – acceptance of the genome editing, and the technological factor – developments for CRISPR. Thus, the genome editing market report provides all the major factors, such as drivers, restraints, opportunities, trends that are impacting the growth of the genome editing in the forecasted period.
The genome editing market was valued at US$ 3,210.1 in 2017 and is expected to reach US$ 10,691.0 Mn in 2025. The market is estimated to grow with a CAGR of 17.0% from 2017-2025.
In our study of genome editing market, the segmentation is done into three major segments such as technology, application, and end user. The technology segment is divided into transcription activator-like effector nucleases (TALENS), clustered regularly interspaced short palindromic repeats (CRIPSR), zinger finger nuclease (ZFNs), antisense RNA and others. The application segment consists of genetic engineering, cell line engineering and others. The genetic engineering is further divided into animal genetic engineering and plant genetic engineering. Similarly, the end user is classified as biotechnology & pharmaceutical companies, contract research organization, academic & government research organization and other end users.
Genome editing is a techniques that is used for the changing the DNA of a cell of an organism. The technique involves cutting of DNA sequences for the addition or the removal of the DNA in the genome. The targeted stakeholders for the reports include service providers, vendors, research institutes, supplier, and distributors of genome editing technologies.
The objective or the scope the study was defining, describing, and forecasting the genome editing market on the basis of technology, application, end user and region. In addition, analyzing the market structure, profiling the key players of the market, and comprehensively analyzing their core competencies. Tracking and analyzing competitive developments such as new product launches; market consolidations and clinical trials and other developments in the genome editing market. Moreover, the aim of the study was providing detailed information regarding the major factors or the reasons that are influencing the growth of the market in the five major regions such as North America, Europe, Asia Pacific, Middle East and Africa and South and Central America.
The prominent players operating in genome editing market include Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., Thermo Fisher Scientific Inc., GenScript, Lonza, Horizon Discovery Group plc, Sangamo Therapeutics, Inc., New England Biolabs, Editas Medicine and Merck KGaA.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.